XML 37 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Beginning Balance, Amount at Dec. 31, 2015 $ 7,998,142 $ 68,908 $ 7,929,234  
Beginning Balance, Shares at Dec. 31, 2015   6,890,808    
Member contribution (successor) 775,949   775,949  
Member distribution (successor) (2,481,178)   (2,346,859) $ (134,319)
Fuse capital, net 1,290,076 $ 90,000 4,082,243 (2,882,167)
Fuse capital, net, Shares   9,000,000    
Net income 3,016,486     3,016,486
Ending Balance, Amount at Dec. 31, 2016 10,599,475 $ 158,908 10,440,567  
Ending Balance, Shares at Dec. 31, 2016   15,890,808    
Restricted stock awards granted 42,609 $ 12,675 29,934  
Restricted stock awards granted, Shares   3,267,500    
Purchase of CPM Medical Consultants, LLC (19,244,543) $ 500,000 (19,744,543)  
Purchase of CPM Medical Consultants, LLC, Shares   50,000,000    
Deferred tax asset 375,278   375,278  
Member contribution (successor) 1,738,620   1,738,620  
Member distribution (successor) (2,192,626)   (1,492,948) (699,678)
Net income 699,678     $ 699,678
Ending Balance, Amount at Dec. 31, 2017 $ (7,981,509) $ 671,583 $ (8,653,092)  
Ending Balance, Shares at Dec. 31, 2017   69,158,308